The bill enacts new sections 3727.81, 3727.811, and 5119.192 of the Revised Code, which mandate that hospitals provide overdose reversal drugs to patients under specific circumstances. According to section 3727.81, hospitals are required to offer an overdose reversal drug at the time of a patient's discharge from the emergency department if the patient exhibited symptoms of an opioid overdose or related issues. However, there are exceptions where a hospital is not obligated to provide the drug, such as if the treating practitioner deems it inappropriate, the patient already possesses the drug, the hospital lacks a supply, or the patient refuses it. Additionally, hospitals must provide information on the drug's use and related services.

Section 3727.811 requires hospitals to document instances of overdose reversal drug provision and submit reports to the departments of health and mental health and addiction services, ensuring patient anonymity. Section 5119.192 outlines that the department of mental health and addiction services will supply hospitals with overdose reversal drugs, contingent on available funding, and will establish reporting standards in collaboration with the department of health. The bill aims to enhance the response to opioid overdoses and improve patient care while providing legal protections for hospitals and their staff involved in administering these drugs.